Tolerability and effectiveness of prochlorperazine for intractable migraine in children

Pediatrics
Marielle A KabboucheAndrew D Hershey

Abstract

To study the effectiveness of prochlorperazine in aborting severe, intractable migraines in children. Patients for this study were drawn from the population seen and evaluated in the Headache Center at Cincinnati Children's Hospital Medical Center. All patients were diagnosed with migraine headache by both clinical and International Headache Society criteria. The effectiveness of intravenous prochlorperazine in 20 consecutive patients referred to the emergency department for severe, prolonged migraines was retrospectively reviewed. Patients evaluated in this study presented with a mean headache severity of 8.4 on a 0- to 10-point scale and an average duration of 54 hours. At 1 hour, 90% of the patients reported feeling better with 50% becoming pain-free. A 50% or greater reduction in severity occurred in 75% of patients at 1 hour and in 95% at 3 hours. At 3 hours, 95% of the patients reported feeling better, and 60% were pain-free. Only 1 patient failed to respond to prochlorperazine. Prochlorperzaine was shown to be highly effective in aborting intractable migraines in children. It was well tolerated with no significant side effects. Additional large, double-blinded, randomized, placebo-controlled studies are needed to further...Continue Reading

Citations

Sep 15, 2005·Current Pain and Headache Reports·Marielle A Kabbouche, Steven L Linder
Sep 2, 2006·Current Pain and Headache Reports·Andrew D HersheyScott W Powers
Oct 14, 2005·Current Treatment Options in Neurology·Andrew D Hershey
Feb 10, 2007·Current Treatment Options in Neurology·Paul WinnerAndrew D Hershey
Sep 16, 2010·Current Treatment Options in Neurology·Hope L O'BrienAndrew D Hershey
Mar 19, 2004·The Journal of Emergency Medicine·David R Vinson
May 14, 2008·Current Opinion in Pediatrics·David M Walker, Stephen J Teach
May 23, 2008·Pediatric Emergency Care·Benoit Bailey, Barbara Cummins McManus
Sep 15, 2007·Journal of Paediatrics and Child Health·Shawna SilverPhilip Gerretsen
Sep 27, 2006·CNS Drugs·Mirja L Hämäläinen
Feb 7, 2014·Current Pain and Headache Reports·Christopher B Oakley, Eric H Kossoff
Feb 18, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Melissa Lau Moon LinL Lee Dupuis
Oct 9, 2012·Expert Review of Neurotherapeutics·Irene ToldoPier Antonio Battistella
Apr 2, 2003·Expert Opinion on Pharmacotherapy·Andrew D Hershey
Mar 29, 2016·Seminars in Pediatric Neurology·Marielle Kabbouche, Chaouki K Khoury
Jan 23, 2016·Headache·Irene R Patniyot, Amy A Gelfand
Sep 12, 2012·Pediatric Neurology·Amy A Gelfand, Peter J Goadsby
Feb 8, 2011·The American Journal of Emergency Medicine·Evelyne D TrottierAnne Lortie
Jun 15, 2010·Seminars in Pediatric Neurology·Marielle A Kabbouche, Catalina Cleves
Jul 16, 2005·Pediatric Annals·Marielle A Kabbouche, Steven L Linder
Jul 30, 2010·Pediatric Annals·Andrew D HersheyScott W Powers
Jan 20, 2009·The Journal of Emergency Medicine·Evelyne D TrottierJocelyn Gravel
Apr 20, 2005·Headache·Hua C SiowStephen D Silberstein
Sep 27, 2003·Headache·R Michael Gallagher, Loretta Mueller
Mar 13, 2009·Headache·Rakesh KhatriBrenda Wong
Feb 12, 2014·Headache·David C SheridanGarth D Meckler
Feb 12, 2014·Headache·Jessica M Kanis, Nathan L Timm
Feb 14, 2015·The American Journal of Emergency Medicine·Steven ChanNathan Timm
Oct 17, 2013·The Journal of Pediatrics·Marielle Kabbouche, Andrew D Hershey
Feb 24, 2015·Current Neurology and Neuroscience Reports·Michael J Marmura, Stephanie Wrobel Goldberg
Dec 17, 2014·Pediatric Neurology·Elana PinchefskyMichael Shevell
Jan 27, 2015·Current Treatment Options in Neurology·Hope L O'BrienAndrew D Hershey
Sep 12, 2015·Pediatric Emergency Care·Courtney R J KaarAlbert K Nakanishi
Jan 21, 2016·Therapeutic Advances in Neurological Disorders·Joanne KacperskiJessica L Weberding
Mar 14, 2018·JAMA Neurology·Carlyn Patterson-Gentile, Christina L Szperka
Sep 21, 2018·Current Opinion in Pediatrics·Shalonda K SlaterHope L O'Brien
Jul 9, 2020·Current Pain and Headache Reports·Klaus WernerAndrew D Hershey
Dec 12, 2018·Expert Opinion on Pharmacotherapy·P BarbantiG Egeo
May 16, 2020·Current Neurology and Neuroscience Reports·Elizabeth Troy, Marcy Yonker
Nov 2, 2018·Current Neurology and Neuroscience Reports·Reena Gogia RastogiRobert Little
May 21, 2020·Pediatric Neurology·Afsaneh Talai, Benjamin Heilbrunn
Aug 5, 2021·Pediatric Quality & Safety·Adam A VukovicEileen Murtagh-Kurowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.